Nexus Pharmaceuticals
Connecting Molecules to Medicine® since 2003
Nexus Wins Patent Litigation for Injectable Cyclophosphamide, Paving Way for Generic
Nexus Wins Patent Litigation for Injectable Cyclophosphamide, Paving Way for Generic
Nexus Wins Patent Litigation For Injectable Cyclophosphamide, Paving Way For Generic
News & Press Releases
News & Press Releases
Join Our Team!
Join Our Team!
EMERPHED® (Ephedrine Sulfate) RTU Injection
EMERPHED® (Ephedrine Sulfate) RTU Injection
Choose The Simplicity, Stability, And Safety Of EMERPHED* Ready-To-Use Ephedrine From Nexus Pharmaceuticals.
Learn more about Nexus!
Learn more about Nexus!
Nexus Pharmaceuticals is a US-based, family-owned, minority-led pharmaceutical manufacturer. Since our inception in 2003, we have been a pioneer in the generic and specialty injectable drug industry. We strive to fulfill critical unmet medical needs and deliver dependable life-saving treatment options when and where they are needed most. Our robust pipeline features several launches of first-to-market FDA-approved generic drugs, spanning therapeutic categories from cardiovascular, oncology, antispasmodic, and anti-epileptic.
LinkedIn
LinkedIn
YouTube
YouTube
Instagram
Instagram
Facebook
Facebook
X
X
View on mobile